Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 5Genitourinary 4Head & Neck 3Gastrointestinal 2Dermatologic 2Plasma cell 1Other solid neoplasm 1Other neoplasm 1Lymphoid 1Gynecologic 1Endocrine 1Breast 1

Conditions

Precancerous Conditions 1Melanoma 1Hepatitis C 1

Interventions

Oxycodone 2tremelimumab 1penpulimab 1peginterferon alfa-2b 1Zoledronic Acid 1Zidovudine 1Whole-Body Irradiation 1Valproic Acid 1Tetradecanoylphorbol Acetate 1Surveys and Questionnaires 1Sodium Chloride 1Selenium 1Rosuvastatin Calcium 1Rituximab 1Ribavirin 1Radiosurgery 1Proflavine 1Peripheral Blood Stem Cell Transplantation 1Patient Reported Outcome Measures 1Observation 1Moxifloxacin 1Morphine 1Microarray Analysis 1Methotrexate 1Methadone 1Laser Therapy 1Interferon alpha-2 1Infliximab 1Gene Expression Profiling 1Gadolinium DTPA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × tremelimumab × Other neoplasm × Clear all
NCT00897312 2016-04-25

Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease

Vanderbilt-Ingram Cancer Center

Terminated
7 enrolled
DermatologicOther neoplasm

Hepatitis C, Melanoma, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡